Abstract Number: PB0932
Meeting: ISTH 2022 Congress
Theme: Venous Thromboembolism » Cancer Associated Thrombosis
Background: Arterial or venous thrombosis can complicate cancer. Up to 20% of oncology patients develop venous thromboembolism (VTE), and VTE is not uncommon in haemato-oncology. However, haemoto-oncology is complicated by thrombocytopenia.
Aims: To access the knowledge and practice of haematologists in Nigeria as regards the management of thrombocytopenia and cancer-associated thrombosis (CAT).
Methods: This was a survey that was shared electronically with haematologists in Nigeria over a period of 6 months using a pretested questionnaire. The questionnaire tested participants’ knowledge and management practices of thrombocytopenia in CAT in haemato-oncology. Data were managed with Microsoft Excel and analysed using statistical package for social sciences version 21.
Results: We had 106 respondents, 70(66%) were Consultant Haematologists, about 30.2% of the respondents saw 6-10 haemato-oncology patients in a month. Fifty-Seven (53.8%) of the respondents risk assessed their patients for CAT, 63 (59.4%) of the respondents saw 1-2 haemato-oncology patients with thrombosis in 3 months. The most common mode of treatment was pharmacological – 94(88%) of respondents used low molecular weight heparin. The most common haemato-oncology associated with thrombocytopenia was Acute leukemias 69(67%). The most common decision taken by respondents was to stop anticoagulants and transfuse platelets because the most frequent concern was the risk of bleeding in this group of patients.
Conclusion(s): Many haematologists have a high level of awareness, knowledge, and good practice regarding thrombocytopenia in CAT in Haemato-oncology patients, however, there is a need for improved knowledge and unified protocols for treatment in line with newer treatment guidelines.
Imagine
Figure 1a: Number of haemato-oncology patients seen per month; Figure 1b: Frequency of thrombocytopenia in haemato-oncology patients.
To cite this abstract in AMA style:
Okoye H, Korubo K, Omunakwe H, Efobi C, Onodingene N, Ugwu N. Survey on the management of cancer associated thrombosis (CAT) in haemato-oncology patients with thrombocytopenia [abstract]. https://abstracts.isth.org/abstract/survey-on-the-management-of-cancer-associated-thrombosis-cat-in-haemato-oncology-patients-with-thrombocytopenia/. Accessed October 1, 2023.« Back to ISTH 2022 Congress
ISTH Congress Abstracts - https://abstracts.isth.org/abstract/survey-on-the-management-of-cancer-associated-thrombosis-cat-in-haemato-oncology-patients-with-thrombocytopenia/